ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

A Phase I Trial of Nab-Paclitaxel/Bevacizumab (AB160) Nano-Immunoconjugate Therapy for Gynecologic Malignancies.

Eleftheria Kalogera et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.